Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -1.00 (-0.45%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £116.68m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

30 Oct 2014 07:00

RNS Number : 6537V
Microgen PLC
30 October 2014
 



microgen

www.microgen.com 30 October 2014

 

INTERIM MANAGEMENT STATEMENT

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2014 to the date of this announcement. Microgen released its interim results for the six months ended 30 June 2014 on 21 July 2014.

 

There have been no significant changes since 1 July 2014 in the trading or financial position of Microgen and its balance sheet remains strong. Both of the Group's businesses, Aptitude Software and Financial Systems, continue to perform satisfactorily in line with the Board's current expectations. In line with the Group's seasonal cash flow cycle and the normal variation in timing of customer receipts the Group had cash at 30 September 2014 of £34.7 million (30 June 2014: £37.9 million) and net funds of £17.7 million (30 June 2014: £20.2 million).

 

Investment has continued in the Aptitude Software business with the release of the latest version of the Aptitude technology platform in October. This software version further extends the Aptitude Big Data processing capabilities enabling users to build data-driven applications deploying Aptitude's in-memory, in-database and in-Hadoop processing. In conjunction with this release, the Aptitude Software business has entered into a partnership with Cloudera, the leading distributor of Apache Hadoop. In October, the Aptitude Software business also released the Compact Edition of the Aptitude Accounting Hub, a pre-configured Aptitude-based divisional accounting hub and sub-ledger which complements the Aptitude Revenue Recognition Engine and the Aptitude Allocation Engine released earlier in the year.

 

In August, Aptitude Software signed a contract with a large North American telecommunications company, which is anticipated to generate revenues in excess of $5 million over its expected term. Discussions are also underway with a number of other telecommunications companies related to the potentially very high volume data processing demands associated with the new IFRS 15 (customer contract revenue recognition) accounting requirements.

 

Financial Systems' wealth management product for trust and fund administration, 5Series, continues to be well received in the market with three new contracts entered into since 1 July 2014. In line with the Board's strategy, the Financial Systems' Application Management business continues to decline slowly as some legacy products/solutions approach end of life. A number of add-on acquisitions in the wealth management sector continue to be progressed, although the Board remains prudent and, as always, there can be no certainty that any acquisitions will be completed.

 

Microgen is continuously identifying and evaluating businesses and strategic investments which the Board believes may benefit from being operated as a business unit under Microgen's stewardship. The Board will maintain its prudent approach and there can be no certainty that any material acquisition will be completed.

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMLBPTMBTTBFI
Date   Source Headline
31st Aug 20177:00 amRNSAcquisition of RevStream
18th Aug 20174:36 pmRNSHolding(s) in Company
11th Aug 201710:47 amRNSAward of Options
4th Aug 20179:50 amRNSHolding(s) in Company
25th Jul 20173:50 pmRNSHolding(s) in Company
24th Jul 20171:12 pmRNSHolding(s) in Company
24th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSTrading Update and Notice of Results
30th Jun 20172:11 pmRNSTotal Voting Rights
21st Jun 20173:06 pmRNSHolding(s) in Company
2nd Jun 20171:43 pmRNSTotal Voting Rights
1st Jun 20177:00 amRNSHolding(s) in Company
17th May 20177:00 amRNSDirector Declaration
17th May 20177:00 amRNSHolding(s) in Company
12th May 201712:08 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHolding(s) in Company
24th Apr 201712:15 pmRNSResult of AGM
24th Apr 20177:00 amRNSAGM Trading update
11th Apr 20174:09 pmRNSHolding(s) in Company
3rd Apr 20177:00 amRNSBlock listing Interim Review
21st Mar 201712:51 pmRNSHolding(s) in Company
17th Mar 201711:22 amRNSHolding(s) in Company
16th Mar 20174:31 pmRNSDirector/PDMR Shareholding
14th Mar 20174:32 pmRNSHolding(s) in Company
9th Mar 20174:38 pmRNSHolding(s) in Company
8th Mar 20177:00 amRNSAudited Preliminary Results
28th Feb 20177:00 amRNSDirectorate Change
27th Feb 20177:00 amRNSAcquisition of Primacy Corporation
6th Feb 20173:39 pmRNSHolding(s) in Company
3rd Feb 20175:22 pmRNSHolding(s) in Company
1st Feb 20172:24 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSNotice of Results and Business Update
21st Dec 20163:51 pmRNSDirector/PDMR Shareholding
17th Nov 201610:50 amRNSBlock Listing Application
10th Oct 20169:37 amRNSBlock listing Interim Review
3rd Oct 20169:45 amRNSTotal Voting Rights
4th Aug 20167:00 amRNSDirector/PDMR Shareholding
29th Jul 201612:41 pmRNSHolding(s) in Company
29th Jul 201612:33 pmRNSHolding(s) in Company
25th Jul 20169:32 amRNSHolding(s) in Company
18th Jul 20167:00 amRNSInterim Results
13th Jul 20164:22 pmRNSHolding(s) in Company
6th Jul 20167:00 amRNSNotice of Results
7th Jun 20165:18 pmRNSHolding(s) in Company
27th May 20164:47 pmRNSHolding(s) in Company
27th May 201612:18 pmRNSTotal Voting Rights
27th May 20167:00 amRNSHolding(s) in Company
16th May 20167:00 amRNSACQUISITION OF INFOSCREEN (CYPRUS) LIMITED
4th May 20162:53 pmRNSCompletion of Fleet Disposal
25th Apr 20169:49 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.